Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenue	$ 1,260,000	$ 0
Operating expenses:
Research and development (in the year ended December 31, 2021, net of collaboration funding of $6,055,295)	6,508,055	11,847,902
General and administrative (in the year ended December 31, 2021, net of collaboration funding of $3,197,659)	10,700,334	10,954,923
Total operating expenses	17,208,389	22,802,825
Loss from operations	(15,948,389)	(22,802,825)
Other income (expense), net:
Interest and other income (expense), net	519,639	13,578
Foreign currency transaction gain (loss)	54,757	(96,202)
Total other income (expense), net	574,396	(82,624)
Net loss	$ (15,373,993)	$ (22,885,449)
Net loss per share - basic and diluted	$ (1.08)	$ (2.06)
Weighted average common shares outstanding - basic and diluted	14,268,245	11,121,039